Home Applications 090011 Application 090011
Type ANDA
Sponsor PAR PHARM INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL EQ 5MG BASE;160MG No No 002 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL EQ 10MG BASE;160MG No No 003 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL EQ 5MG BASE;320MG No No 004 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL EQ 10MG BASE;320MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090011-001 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL AB 2013-03-28 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL AB 2013-03-28 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL AB 2013-03-28 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE; VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL AB 2013-03-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-04-04 05:41 UTC 2022-04 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL AB 2013-03-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL AB 2013-03-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL AB 2013-03-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL AB 2013-03-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL 2013-03-28 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL 2013-03-28 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL 2013-03-28 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL 2013-03-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL AB 2013-03-28 3f01610625f2…2019-12-14 00:12 UTC 2019-12 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL AB 2013-03-28 3f01610625f2…2019-12-14 00:12 UTC 2019-12 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL AB 2013-03-28 3f01610625f2…2019-12-14 00:12 UTC 2019-12 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL AB 2013-03-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A090011-001 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;160MG TABLET / ORAL AB 2013-03-28 b00525d2431f…2019-09-15 20:21 UTC 2019-09 A090011-002 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;160MG TABLET / ORAL AB 2013-03-28 b00525d2431f…2019-09-15 20:21 UTC 2019-09 A090011-003 AMLODIPINE BESYLATE AND VALSARTAN EQ 5MG BASE;320MG TABLET / ORAL AB 2013-03-28 b00525d2431f…2019-09-15 20:21 UTC 2019-09 A090011-004 AMLODIPINE BESYLATE AND VALSARTAN EQ 10MG BASE;320MG TABLET / ORAL AB 2013-03-28 b00525d2431f…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 144 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 24 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 42291-020 Amlodipine and Valsartan amlodipine and valsartan AvKARE, Inc. ANDA Current 42291-020 Amlodipine and Valsartan amlodipine and valsartan AvKARE ANDA Current 42291-022 Amlodipine and Valsartan amlodipine and valsartan AvKARE, Inc. ANDA Current 42291-022 Amlodipine and Valsartan amlodipine and valsartan AvKARE ANDA Current 42291-022 Amlodipine and Valsartan amlodipine and valsartan AvKARE ANDA Current 42291-023 Amlodipine and Valsartan amlodipine and valsartan AvKARE, Inc. ANDA Current 49884-574 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 49884-574 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 49884-575 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 49884-575 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 49884-577 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 49884-577 Amlodipine and Valsartan amlodipine and valsartan Par Pharmaceutical, Inc. ANDA Current 64380-214 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-214 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-214 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-215 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-215 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-215 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-216 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-216 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-216 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-217 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-217 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current 64380-217 Amlodipine and Valsartan amlodipine and valsartan Strides Pharma Science Limited ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 31439 ORIG 2013-04-02